R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

NCT05777369 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: Mitoxantrone hydrochloride liposome
DRUG: Cyclophosphamide
DRUG: Vincristine/Vindesine
DRUG: Prednisone

Sponsor

The First Affiliated Hospital with Nanjing Medical University